| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/1999 | EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds |
| 04/28/1999 | EP0910371A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 04/28/1999 | EP0910370A1 Compositions comprising a nitrone compound for use in treating ocular inflammation |
| 04/28/1999 | EP0910369A1 Benzothiophenes, formulations containing same, and methods |
| 04/28/1999 | EP0910368A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
| 04/28/1999 | EP0910367A2 Esters of vitamin e as products for topical application |
| 04/28/1999 | EP0910366A1 Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of hiv to uninfected cells and contraceptive compositions comprising the said derivatives |
| 04/28/1999 | EP0910365A1 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 04/28/1999 | EP0910364A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory |
| 04/28/1999 | EP0910363A1 Veterinary use of a pleuromutilin derivative |
| 04/28/1999 | EP0910362A1 Oxa acids and related compounds for treating skin conditions |
| 04/28/1999 | EP0910361A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction |
| 04/28/1999 | EP0910360A1 Reduction of cardiotoxicity of an antitumor agent using manganese compound |
| 04/28/1999 | EP0910359A1 Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0910357A1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 04/28/1999 | EP0910356A1 Biphenylamido derivatives as melatonergic agents |
| 04/28/1999 | EP0910355A1 Traitement and prevention of adverse effects of reactive oxygen species |
| 04/28/1999 | EP0910354A1 Antioxidant compounds |
| 04/28/1999 | EP0910353A1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 04/28/1999 | EP0910351A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/28/1999 | EP0910349A2 Controlled release tablet |
| 04/28/1999 | EP0910345A1 Biconvex rapidly disintegrating dosage forms |
| 04/28/1999 | EP0910343A1 Emulsion formulations for hydrophilic active agents |
| 04/28/1999 | EP0910331A1 Oxa diacids and related compounds for treating skin conditions |
| 04/28/1999 | EP0910328A1 Aqueous nacreous lustre concentrate |
| 04/28/1999 | EP0910253A1 Peri-operative drink |
| 04/28/1999 | EP0910246A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 04/28/1999 | EP0820280A4 Compositions and methods for treating pain |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 04/28/1999 | EP0775150B1 Endotoxin reduction or removal process |
| 04/28/1999 | EP0737184B1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 04/28/1999 | EP0655907B1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 04/28/1999 | EP0650361B1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 04/28/1999 | EP0650359B1 Transdermal therapeutic system containing the active substance 17- -oestradiol (anhydrous) |
| 04/28/1999 | EP0618907B1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents |
| 04/28/1999 | EP0609440B1 Phosphorus-substituted isoprenoid derivative |
| 04/28/1999 | EP0609328B1 Pyrrolo-pyridazines with gastro-intestinal protective action |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215405A Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215400A Piperazine and piperidine compounds |
| 04/28/1999 | CN1215399A Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 04/28/1999 | CN1215397A Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 04/28/1999 | CN1215396A Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 04/28/1999 | CN1215392A Histamine H3 receptor ligands |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215339A 5 'alpha'-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215335A Method fo treating heart failure with endothelin antagonists |
| 04/28/1999 | CN1215334A Preventive and remedy for viral infections |
| 04/28/1999 | CN1215333A Use of derivativ |
| 04/28/1999 | CN1215332A Use of subsitituted aryl imidazoles |
| 04/28/1999 | CN1215331A Injection formulations of avermectins and milbemycins based on castor oil |
| 04/28/1999 | CN1215330A Antiseptic skin care composition and method for making same |
| 04/28/1999 | CN1215328A Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 04/28/1999 | CN1215311A Diabetic supplement bar |
| 04/28/1999 | CN1215310A Method of killing or inhibiting microbial cells |
| 04/28/1999 | CN1215306A Corneal storage fluid comprised of hyaluronic acid |
| 04/28/1999 | CN1215058A Novel trichain formed eliyonucleotide structure and application to anti-virus of hepatitis B |
| 04/28/1999 | CN1215056A Process for preparation of N-tertiary butyl amide |
| 04/28/1999 | CN1215055A Sesquilterpenic internal ester compound for anti-ulcer of alimentary tract |
| 04/28/1999 | CN1215054A Bychclic fibrinogen antagonists |
| 04/28/1999 | CN1215053A Pharmacologically active enantiomers and method for their preparation |
| 04/28/1999 | CN1215052A Pharmacollogically active enantiomers and method for their preparation |
| 04/28/1999 | CN1215050A Process for preparing enoxacin lactate |
| 04/28/1999 | CN1214927A Process for preparing natural germanium gluconate strengthened medicament and equipment thereof |
| 04/28/1999 | CN1214913A Traditional Chinese medicine preparation for invigorating brain and enhancing fitness of teen-agers |
| 04/28/1999 | CN1214910A Pharmaceutical application of crust holoside and derivant thereof |
| 04/28/1999 | CN1214909A Complex anti-parasite medicine for animal use |
| 04/28/1999 | CN1214908A Process for preparing enoxacin lactate injection |
| 04/28/1999 | CN1214907A Citrate concentrate and preparation process thereof |
| 04/28/1999 | CN1043143C Beta, beta-dihydroxy meso-substituted chlorin, bacteriochlorin, isobacteriochlorin and process for making same |
| 04/28/1999 | CN1043142C Quinolone and naphthyridone-carboxylic acid derivatives and preparation process |
| 04/28/1999 | CN1043141C Heterocyclic amines compound, its preparation process, medicinal composition containing same and medical use thereof |
| 04/28/1999 | CN1043140C Hydroxymethyl furazane carboxylic acid derivatives and its preparation process and medicinal composition |
| 04/28/1999 | CN1043125C Artemisia apiacea amber composition for anti toxoplasmayondii |
| 04/28/1999 | CA2248274A1 Novel dbpa |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5898038 Administering nitroglycerine and a bisphosphonate selected from disodium etidronate, pamidronate, clodronate, residronate or alendronate to the patient suffering from primary and secondary osteoprosis |
| 04/27/1999 | US5898035 A pharmaceutical formulation for the intravenous regional sympathetic blockade treatment comprising an adrenergic blocking agent and pain reliever for reducing hypotensive side-effect |
| 04/27/1999 | US5898034 Psoriasis medication and application for remission and/or cure of plaque psoriasis |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5898032 Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| 04/27/1999 | US5898031 Oligoribonucleotides for cleaving RNA |
| 04/27/1999 | US5898029 Promoting sensitivity of neuronal cell systems to neurotrophic factors by the immunophilin ligands for therapeutic application in diseases involving neural degeneration, nerve damage by physical injury |
| 04/27/1999 | US5897891 Consists of a zinc compound, a mono-carboxylic amino acid, and lesser amount of copper compound; pleasant flavor |
| 04/27/1999 | US5897880 Topical drug preparations |
| 04/27/1999 | US5897879 Sustained-release pharmaceutical system for the delivery of antioxidants |
| 04/27/1999 | US5897875 Treating painful muscular cramp conditions in abdominal cavity comprising administering a therapeutical amount of alpha, alpha-diphenylacetic acid-4(n-methyl-piperidyl)ester |
| 04/27/1999 | US5897871 Therapeutic agent for the treatment of melanomas |
| 04/27/1999 | US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms |
| 04/27/1999 | US5897858 Nasal spray compositions exhibiting increased retention in the nasal cavity |
| 04/27/1999 | US5897857 Depilatory compositions comprising sulfhydryl compounds |
| 04/27/1999 | US5897539 Hormone replacement therapy method and hormone dispenser |
| 04/27/1999 | CA2248119A1 Novel apt |
| 04/27/1999 | CA2248116A1 Novel muty |
| 04/27/1999 | CA2163778C Indole derivatives as steroid 5a-reductase inhibitors |